Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Tolerance of tetrabenazine during long-term treatment.

Mikkelsen BO.

Acta Neurol Scand. 1983 Jul;68(1):57-60.

PMID:
6225292
2.

Tetrabenazine and movement disorders.

Asher SW, Aminoff MJ.

Neurology. 1981 Aug;31(8):1051-4.

PMID:
6455607
3.
4.

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J.

Mov Disord. 2007 Jan 15;22(2):193-7.

PMID:
17133512
5.

Treatment of tardive dyskinesia: preliminary report on use of tetrabenazine.

Watson MW, Skelton D, Jamali F.

Can J Psychiatry. 1988 Feb;33(1):11-3.

PMID:
2965967
6.

Tetrabenazine as a cause of neuroleptic malignant syndrome.

Ossemann M, Sindic CJ, Laterre C.

Mov Disord. 1996 Jan;11(1):95. No abstract available.

PMID:
8771075
7.

Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.

Toglia JU, McGlamery M, Sambandham RR.

J Clin Psychiatry. 1978 Jan;39(1):81-7.

PMID:
147268
8.

Tetrabenazine in the treatment of Huntington's chorea.

Huang CY, McLeod JG, Holland RT, Elliot C.

Med J Aust. 1976 Apr 17;1(16):583-4.

PMID:
132600
9.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Jankovic J.

Expert Rev Neurother. 2006 Jan;6(1):7-17. Review.

PMID:
16466307
10.

Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.

Mateo D, Muñoz-Blanco JL, Giménez-Roldán S.

Clin Neuropharmacol. 1992 Feb;15(1):63-8.

PMID:
1533561
11.

The long-term effect of tetrabenazine in the management of Huntington disease.

Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.

Clin Neuropharmacol. 2008 Nov-Dec;31(6):313-8. doi: 10.1097/WNF.0b013e318166da60.

PMID:
19050408
12.

The effect of tetrabenazine in some hyperkinetic syndromes.

Pakkenberg H.

Acta Neurol Scand. 1968;44(3):391-3. No abstract available.

PMID:
4235247
13.

Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Jankovic J, Beach J.

Neurology. 1997 Feb;48(2):358-62.

PMID:
9040721
14.

Treatment of tardive dyskinesia with choline and tetrabenazine.

Snell AP, Cleary M, Sambrook M.

Postgrad Med J. 1980 Sep;56(659):663-4.

15.

Tetrabenazine for involuntary movement disorders.

Kingston D.

Med J Aust. 1979 Jun 30;1(13):628-30.

PMID:
158700
16.

Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes.

Fog R, Pakkenberg H.

Acta Neurol Scand. 1970;46(2):249-51. No abstract available.

PMID:
4246984
17.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Huntington Study Group.

Neurology. 2006 Feb 14;66(3):366-72.

PMID:
16476934
18.

Tetrabenazine for Huntington's chorea.

Soutar CA.

Br Med J. 1970 Oct 3;4(5726):55. No abstract available.

19.

Combined therapy with tetrabenazine and pimozide in Huntington's chorea: pilot study.

McArthur AW, Pollock M, Smidt NA.

N Z Med J. 1976 Feb 25;83(558):114-6.

PMID:
131917
20.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Jankovic J.

Adv Neurol. 1983;37:277-89. No abstract available.

PMID:
6574695

Supplemental Content

Support Center